Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon A Jones

Showing results (51-60 of 273) with videos related to

Pageof 28
Sort By:
Clinical Pharmacokinetics|December 6, 2018
Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three TrialsYulan Qi, Kathleen McKeever, Julie Taylor, et al.
Orphanet Journal of Rare Diseases|January 7, 2021
Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studiesSuresh Vijay, Anais Brassier, Arunabha Ghosh, et al.
Molecular Genetics and Metabolism|July 20, 2010
Home treatment with intravenous enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II - data from the Hunter Outcome SurveyBarbara K Burton, Nathalie Guffon, Jane Roberts, et al.
Clinical Pharmacokinetics|November 24, 2018
Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three TrialsYulan Qi, Kathleen McKeever, Julie Taylor, et al.
Molecular Genetics and Metabolism|June 22, 2020
Retrospective chart review of urinary glycosaminoglycan excretion and long-term clinical outcomes of enzyme replacement therapy in patients with mucopolysaccharidosesSimon A Jones, Deborah Marsden, Tony Koutsoukos, et al.
Orphanet Journal of Rare Diseases|March 2, 2021
Correction to: Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studiesSuresh Vijay, Anais Brassier, Arunabha Ghosh, et al.
Neonatology|March 5, 2011
Dynamic expression of IL-6 trans-signalling molecules in the lungs of preterm baboons undergoing mechanical ventilationEamon P McGreal, Mallinath Chakraborty, Vicki T Winter, et al.
The American Journal of Pathology|June 27, 2007
Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivoBarbara Coles, Ceri A Fielding, Stefan Rose-John, et al.
Journal of the American College of Radiology : JACR|April 15, 2020
Patient Experience With Notification of Radiology Results: A Comparison of Direct Communication and Patient Portal UseKira Garry, Saul Blecker, Harry Saag, et al.
Journal of Genetic Counseling|February 23, 2018
Parenting a Child with Phenylketonuria (PKU): an Interpretative Phenomenological Analysis (IPA) of the Experience of ParentsKatie Carpenter, Anja Wittkowski, Dougal J Hare, et al.
Pageof 28

Showing results (51-60 of 273) with videos related to

Sort By:
Pageof 28
Clinical Pharmacokinetics|December 6, 2018
Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three TrialsYulan Qi, Kathleen McKeever, Julie Taylor, et al.
Orphanet Journal of Rare Diseases|January 7, 2021
Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studiesSuresh Vijay, Anais Brassier, Arunabha Ghosh, et al.
Molecular Genetics and Metabolism|July 20, 2010
Home treatment with intravenous enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II - data from the Hunter Outcome SurveyBarbara K Burton, Nathalie Guffon, Jane Roberts, et al.
Clinical Pharmacokinetics|November 24, 2018
Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three TrialsYulan Qi, Kathleen McKeever, Julie Taylor, et al.
Molecular Genetics and Metabolism|June 22, 2020
Retrospective chart review of urinary glycosaminoglycan excretion and long-term clinical outcomes of enzyme replacement therapy in patients with mucopolysaccharidosesSimon A Jones, Deborah Marsden, Tony Koutsoukos, et al.
Orphanet Journal of Rare Diseases|March 2, 2021
Correction to: Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studiesSuresh Vijay, Anais Brassier, Arunabha Ghosh, et al.
Neonatology|March 5, 2011
Dynamic expression of IL-6 trans-signalling molecules in the lungs of preterm baboons undergoing mechanical ventilationEamon P McGreal, Mallinath Chakraborty, Vicki T Winter, et al.
The American Journal of Pathology|June 27, 2007
Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivoBarbara Coles, Ceri A Fielding, Stefan Rose-John, et al.
Journal of the American College of Radiology : JACR|April 15, 2020
Patient Experience With Notification of Radiology Results: A Comparison of Direct Communication and Patient Portal UseKira Garry, Saul Blecker, Harry Saag, et al.
Journal of Genetic Counseling|February 23, 2018
Parenting a Child with Phenylketonuria (PKU): an Interpretative Phenomenological Analysis (IPA) of the Experience of ParentsKatie Carpenter, Anja Wittkowski, Dougal J Hare, et al.
Pageof 28